| 211 |
Expanding the scaffold for bacterial RNA polymerase inhibitors: Design, synthesis and structure activity relationships of ureido-heterocyclic-carboxylic acids |
2014 |
| 212 |
Facile Synthesis, Molecular Docking, and Biological Screening of 1,3-Disubstituted Urea Derivatives |
2014 |
| 213 |
In Silico Studies of Quinoxaline-2-Carboxamide 1,4-di-N-Oxide Derivatives as Antimycobacterial Agents |
2014 |
| 214 |
Surface plasmon resonance – more than a screening technology: insights in the binding mode of σ70:core RNAP inhibitors |
2014 |
| 215 |
Synthesis and Characterization of bis-3,5-Disubstituted Thiadiazine-2-thione Derivatives as Anticancer Agents |
2014 |
| 216 |
A Combined Experimental Green Flow-Injection Procedure and Computational Analysis to Determine Amino Acids |
2013 |
| 217 |
Assessment of New Anti-HER2 Ligands Using Combined Docking, QM/MM Scoring and MD Simulation |
2013 |
| 218 |
Design, Synthesis and Molecular Docking of Some New 1,2,4-Triazolobenzimidazol-3-yl Acetohydrazide Derivatives with Anti-Inflammatory-Analgesic Activities |
2013 |
| 219 |
Design, Synthesis and Molecular Docking of Some New 1,2,4-Triazolobenzimidazol-3-yl Acetohydrazide Derivatives with Anti-Inflammatory-Analgesic Activities |
2013 |
| 220 |
Design, Synthesis and Molecular Docking of Some New 1,2,4-Triazolobenzimidazol-3-yl Acetohydrazide Derivatives with Anti-Inflammatory-Analgesic Activities |
2013 |
